Immunofan,. 45 µg/ml 1 ml 5 pcs

Used in adults and children over two years for the prevention and treatment of immunodeficiency and toxic conditions, chronic inflammatory diseases of various etiologies.

Indications

Used in adults and children over two years of age for the prevention and treatment of immunodeficiency and toxic conditions, chronic inflammatory diseases of various etiologies.

Pharmacological effect

Pharmacotherapeutic group:

Special instructions

As a result of activation of phagocytosis, a short-term exacerbation of foci of chronic inflammation, maintained due to the persistence of viral or bacterial antigens, is possible.

Active ingredient

Arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine

Composition

Active substance:

imunofan – 50 mcg.

Pregnancy

Due to insufficient knowledge, it should be used with caution during pregnancy and lactation.

Contraindications

Hypersensitivity, pregnancy complicated by Rh conflict, children under 2 years of age.

Side Effects

Individual intolerance is possible.

Interaction

Increases the effectiveness of other types of drug therapy: the use of imunofan helps overcome resistance to glucocorticosteroid therapy.

The drug can be prescribed in combination with anti-inflammatory steroidal and non-steroidal anti-inflammatory drugs.

Storage conditions

In a dry place, protected from light, at a temperature of 2–10 °C

Shelf life

2 years

Manufacturer

Moscow Endocrine Plant, Russia